Genetic testing firm 23andMe shows certain blood types are less likely to contract coronavirus
- The company in April launched a study using the millions of profiles in its DNA database to shed light on the role genetics play in the disease
- Preliminary results from more than 750,000 participants suggests type O blood is especially protective against the coronavirus

Research from genetic testing giant 23andMe found differences in a gene that influences a person’s blood type can affect a person’s susceptibility to Covid-19.
Preliminary results from more than 750,000 participants suggests type O blood is especially protective against Sars-CoV-2, the virus that causes Covid-19, the company said on Monday. The findings echo other research that has indicated a link between variations in the ABO gene and Covid-19.
Many other groups, including 23andMe competitor Ancestry, are combing the genome to help make sense of the virus. It is known that factors such as age and underlying health conditions can determine how people fare once they’ve contracted Covid-19.
Several other studies looking at both severity of illness and susceptibility to disease have also suggested blood type plays a role.
Research published last week prior to peer review suggested blood type may play a role in the severity of patients’ reactions to Sars-CoV-2. That study looked at the genes of more than 1,600 patients in Italy and Spain who experienced respiratory failure and found that having type A blood was linked to a 50 per cent increase in the likelihood a patient would require a ventilator. An earlier Chinese study turned up similar results regarding a person’s susceptibility to Covid-19.